Y. Freund-Levi

Discipline

Psychologie (6)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

Biochemical markers (9) Alzheimer's disease (9) Amyloid (8) biomarqueur (7) Human beings (6) protéine (5) pathologie (5) âge (5) Weights and measures (5) Proteins (5) Pathology (5) Cerebrospinal fluid (5) Age (5) Age (5) plasma (5) information (4) maladie (4) Apolipoprotein E (4) Performance (4) Dementia (4) Brain (4) Mild cognitive impairment (4) Proteomics (4) Performance (4) cerveau (4) maladie (4) test (3) Area (3) Area (3) Persons (3)

Documents écrit par Y. Freund-Levi (9) | parle de Y. Freund-Levi (0)

Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
A. Delvenne et al. (14 juin 2022)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
W.J. Jansen et al. (2015)